News

Bisphosphonate Use May Be Linked to Reduced Colorectal Cancer Risk

Publish date: January 27, 2011

 

Dr. Rennert reported that he had no relevant conflicts of interest.

Pages

Recommended Reading

Rifaximin May Relieve Symptoms in Some Patients With IBS
MDedge Internal Medicine
Bariatric Surgery Safer than Ever
MDedge Internal Medicine
Making a Diagnosis of Celiac Disease Can Be Tricky
MDedge Internal Medicine
FDA Panel: Exocrine Pancreatic Insufficiency Treatment Risks Outweigh Benefits
MDedge Internal Medicine
FDA Panel: Exocrine Pancreatic Insufficiency Treatment Risks Outweigh Benefits
MDedge Internal Medicine
FDA Warns of Possible Liver Injury With Dronedarone
MDedge Internal Medicine
Anal Cancer: IMRT Less Toxic Than Conventional RT
MDedge Internal Medicine
Genomic Profile Predicts Recurrence Risk in Colorectal Cancer
MDedge Internal Medicine
PET-Detected Response to Chemo Means Better Prognosis in Esophagogastric Junction Cancer
MDedge Internal Medicine
Food Allergy Guidelines Encourage Earlier Use of IM Epinephrine
MDedge Internal Medicine